Aspen Aerogels: Stability With Some Green Shoots In Sight
Aspen Aerogels is navigating a challenging recovery phase after significant revenue declines. The company reported a 50% drop in Q1 revenues but has shown sequential EBITDA improvement and maintains a strong cash position. Management aims for EBITDA break-even by the second half of 2026 as they implement cost reductions.
- ▪Aspen Aerogels' Q1 revenues fell over 50% to $37.9 million.
- ▪The company has a net cash position of $100 million, providing operational runway.
- ▪Management is targeting EBITDA break-even at a $200 million annualized sales run rate in H2 2026.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Basic Materials","item":"https://seekingalpha.com/stock-ideas/basic-materials"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907386-aspen-aerogels-stability-with-some-green-shoots-in-sight"},"author":{"@type":"Person","name":"The Value Investor","url":"https://seekingalpha.com/author/the-value-investor"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
